Stopping traffic in Sjögren's syndrome

Arthritis and Rheumatism

Volumn 54, Issue 4, 2006, Pages 1061-1062

  Cohen, Philip L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CYTOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2 RECEPTOR; MONOKINE;

ANTIGEN SPECIFICITY; AUTOIMMUNITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; EDITORIAL; HUMAN; INTERFERON PRODUCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; HUMANS; MICE; RECEPTORS, CHEMOKINE; SJOGREN'S SYNDROME; T-LYMPHOCYTES;

EID: 33646356701     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21746     Document Type: Editorial

References (9)

1. Hasegawa H, Inoue A, Kohno M, Muraoka M, Miyazaki T, Terada M, et al. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis iin MRL/lpr mice. Arthritis Rheum 2006;54:1174-83.
2. Cascieri MA, Springer MS. The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. Curr Opin Chem Biol 2000;4:420-7.
3. Lazzeri E, Romagnani P. CXCR3-binding chemokines: novel multifunctional therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord 2005;5:109-18.
4. Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S. Involvement of the interferon-γ-induced T cell-attracting chemokines, interferon-γ- inducible 10-kd protein (CXCL10) and monokine induced by interferon-γ (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis Rheum 2002;46:2730-41.
5. Amft N, Bowman SJ. Chemokines and cell trafficking in Sjogren's syndrome. Scand J Immunol 2001;54:62-9.
6. Liu L, Callahan MK, Huang D, Ransohoff RM. Chemokine receptor CXCR3: an unexpected enigma. Curr Top Dev Biol 2005;68:149-81.
7. Humphreys-Beher MG. Animal models for autoimmune disease-associated xerostomia and xerophthalmia. Adv Dent Res 1996;10:73-5.
8. Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ, et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum 2005;52:1773-84.
9. Johnson Z, Power CA, Weiss C, Rintelen F, Ji H, Ruckle T, et al. Chemokine inhibition-why, when, where, which and how? Biochem Soc Trans 2004;32:366-77.